BIOGEN INTERNATIONAL GMBH – Trademark Portfolio

Entity Type: 27

BIOGEN INTERNATIONAL GMBH holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 9 filings in this category. Currently, 5 trademarks are registered. Notable registered marks include OPUVIZ, BYOOVIZ, OPAXVIZ, and TOFIDENCE. The owner is based in BAAR.

NEUHOFSTRASSE 30, 6340

BAAR , CH

9 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

RIMPOVIZ
RIMPOVIZ
Abandoned 2022
OPAXVIZ
OPAXVIZ
Registered 2021
OPUVIZ
OPUVIZ
Registered 2021
TOFIDENCE
TOFIDENCE
Registered 2021
Trademark
Serial #97159689
Registered 2021
BYOOVIZ
BYOOVIZ
Registered 2020

Trademark Classifications

BIOGEN INTERNATIONAL GMBH's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (9 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does BIOGEN INTERNATIONAL GMBH have?

BIOGEN INTERNATIONAL GMBH has 9 U.S. trademarks filed with the USPTO. Of these, 5 registered, 4 abandoned.

What trademark classes does BIOGEN INTERNATIONAL GMBH file in?

BIOGEN INTERNATIONAL GMBH files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are BIOGEN INTERNATIONAL GMBH's most well-known trademarks?

BIOGEN INTERNATIONAL GMBH's registered trademark portfolio includes well-known marks such as OPUVIZ, BYOOVIZ, OPAXVIZ, and TOFIDENCE. These are among 5 currently registered trademarks in the portfolio.

What is BIOGEN INTERNATIONAL GMBH's trademark registration success rate?

BIOGEN INTERNATIONAL GMBH has a 56% trademark registration rate, with 5 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.